{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:00:41Z","timestamp":1750309241630,"version":"3.41.0"},"publisher-location":"Cham","reference-count":97,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319483801"},{"type":"electronic","value":"9783319483825"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-48382-5_20","type":"book-chapter","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T12:46:34Z","timestamp":1496666794000},"page":"469-487","source":"Crossref","is-referenced-by-count":3,"title":["Lipotoxicity-Related Hematological Disorders in Obesity"],"prefix":"10.1007","author":[{"given":"Ibrahim Celalettin","family":"Haznedaroglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umit Yavuz","family":"Malkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"key":"20_CR1","doi-asserted-by":"crossref","first-page":"23494","DOI":"10.1074\/jbc.M110.117481","volume":"285","author":"J Abd Alla","year":"2010","unstructured":"Abd Alla, J., et al. 2010. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis. Journal of Biological Chemistry 285: 23494\u201323503.","journal-title":"Journal of Biological Chemistry"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00016340701552434","volume":"86","author":"K Acar","year":"2007","unstructured":"Acar, K., Y. Beyazit, A. Sucak, et al. 2007. Alterations in the \u2018local umbilical cord blood renin-angiotensin system\u2019 during pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica 86: 1\u20137.","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"20_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ijo.0801501","volume":"24","author":"G Ailhaud","year":"2000","unstructured":"Ailhaud, G., A. Fukamizu, F. Massiera, R. Negrel, P. Saint-Marc, and M. Teboul. 2000. Angiotensinogen, angiotensin II and adipose tissue development. International Journal of Obesity and Related Metabolic Disorders 24: 33\u201335.","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"20_CR4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/10428190500399250","volume":"47","author":"S Aksu","year":"2006","unstructured":"Aksu, S., Y. Beyazit, I.C. Haznedaroglu, et al. 2006. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leukemia & Lymphoma 47: 891\u2013896.","journal-title":"Leukemia & Lymphoma"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.HYP.36.4.638","volume":"36","author":"K Arakawa","year":"2000","unstructured":"Arakawa, K., and H. Urata. 2000. Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Hypertension 36: 638\u2013641.","journal-title":"Hypertension"},{"issue":"5","key":"20_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00774-009-0078-2","volume":"27","author":"M Aryan","year":"2009","unstructured":"Aryan, M., A. Kepez, E. Atalar, et al. 2009. Association of plasma osteopontin levels with coronary calcification evaluated by tomographic coronary calcium scoring. Journal of Bone and Mineral Metabolism 27(5): 591\u2013597.","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"6","key":"20_CR7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/00207230500120443","volume":"16","author":"E Atalar","year":"2005","unstructured":"Atalar, E., I.C. Haznedaroglu, H. Kilic, et al. 2005. Increased soluble glycoprotein V concentration during the acute onset of unstable angina pectoris in association with chronic cigarette smoking. Platelets 16(6): 329\u2013333.","journal-title":"Platelets"},{"key":"20_CR8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.HYP.35.1.329","volume":"35","author":"M Barton","year":"2000","unstructured":"Barton, M., R. Carmona, H. Morawietz, L. d\u2019Uscio, W. Goettsch, H. Hillen, C. Haudenschild, J. Krieger, K. Munter, T. Lattmann, T. Luscher, and S. Shaw. 2000. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: Evidence for a regulatory role of endothelin. Hypertension 35: 329\u2013336.","journal-title":"Hypertension"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00059-010-3360-0","volume":"35","author":"MU Becher","year":"2010","unstructured":"Becher, M.U., et al. 2010. Regeneration of the vascular compartment. Herz 35: 342\u2013350.","journal-title":"Herz"},{"key":"20_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11906-010-0171-x","volume":"13","author":"UM Becher","year":"2011","unstructured":"Becher, U.M., et al. 2011. Endothelial damage and regeneration: The role of the Renin Angiotensin-aldosterone system. Current Hypertension Reports 13: 86\u201392.","journal-title":"Current Hypertension Reports"},{"key":"20_CR11","first-page":"57","volume":"99","author":"Y Beyazit","year":"2007","unstructured":"Beyazit, Y., S. Aksu, I.C. Haznedaroglu, et al. 2007. Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. Journal of the National Medical Association 99: 57\u201363.","journal-title":"Journal of the National Medical Association"},{"key":"20_CR12","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/714515","volume":"2011","author":"Y Beyazit","year":"2010","unstructured":"Beyazit, Y., T. Purnak, G.S. Guven, and I.C. Haznedaroglu. 2010. Local bone marrow Renin-Angiotensin system and atherosclerosis. Cardiology Research and Practice 2011: 714515. doi: 10.4061\/2011\/714515 .","journal-title":"Cardiology Research and Practice"},{"issue":"7","key":"20_CR13","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1007\/s10620-011-1580-7","volume":"56","author":"Y Beyazit","year":"2011","unstructured":"Beyazit, Y., M. Ibis, T. Purnak, et al. 2011. Elevated levels of circulating angiotensin converting enzyme in patients with hepatoportal sclerosis. Digestive Diseases and Sciences 56(7): 2160\u20132165. doi: 10.1007\/s10620-011-1580-7 .","journal-title":"Digestive Diseases and Sciences"},{"key":"20_CR14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.ATV.0000254680.71485.92","volume":"27","author":"LA Cassis","year":"2007","unstructured":"Cassis, L.A., D.L. Rateri, H. Lu, and A. Daugherty. 2007. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin I\u0131induced atherosclerosis and aneurysms. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 380\u2013386.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"20_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.ATV.0000097769.47306.12","volume":"24","author":"MK Cathcart","year":"2004","unstructured":"Cathcart, M.K. 2004. Regulation of superoxide anion production by NADPH oxidase in monocytes\/macrophages: Contributions to atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 23\u201328.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2008.07.010","volume":"151","author":"M Coppo","year":"2008","unstructured":"Coppo, M., et al. 2008. Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes. Regulatory Peptides 151: 1\u20136.","journal-title":"Regulatory Peptides"},{"key":"20_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.109.144964","volume":"55","author":"SD Crowley","year":"2010","unstructured":"Crowley, S.D., et al. 2010. A role for angiotensin II Type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension. Hypertension 55: 99\u2013U180.","journal-title":"Hypertension"},{"key":"20_CR18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","volume":"21","author":"P Dandona","year":"2007","unstructured":"Dandona, P., S. Dhindsa, H. Ghanim, and A. Chaudhuri. 2007. Angiotensin II and inflammation: The effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. Journal of Human Hypertension 21: 20\u201327.","journal-title":"Journal of Human Hypertension"},{"key":"20_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11883-010-0109-4","volume":"12","author":"A Daugherty","year":"2010","unstructured":"Daugherty, A., et al. 2010. Genetic variants of the renin angiotensin system: Effects on atherosclerosis in experimental models and humans. Current Atherosclerosis Reports 12: 167\u2013173.","journal-title":"Current Atherosclerosis Reports"},{"key":"20_CR20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","volume":"52","author":"M De Gasparo","year":"2000","unstructured":"De Gasparo, M., K.J. Catt, T. Inagami, J.W. Wright, and T. Unger. 2000. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacological Reviews 52: 415\u2013472.","journal-title":"Pharmacological Reviews"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.ATV.0000078521.51319.65","volume":"23","author":"G Desideri","year":"2003","unstructured":"Desideri, G., M.C. Bravi, M. Tucci, G. Croce, M.C. Marinucci, A. Santucci, et al. 2003. Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 1218\u20131223.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"20_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.abb.2016.02.001","volume":"593","author":"LP Dolgacheva","year":"2016","unstructured":"Dolgacheva, L.P., M.V. Turovskaya, V.V. Dynnik, et al. 2016. Angiotensin II activates different calcium signaling pathways in adipocytes. Archives of Biochemistry and Biophysics 593: 38\u201349.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"20_CR23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00004872-200105000-00001","volume":"19","author":"M Epstein","year":"2001","unstructured":"Epstein, M. 2001. Aldosterone and the hypertensive kidney: Its emerging role as a mediator of progressive renal dysfunction: A paradigm shift. Journal of Hypertension 19: 829\u2013842.","journal-title":"Journal of Hypertension"},{"key":"20_CR24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0895-7061(99)00145-4","volume":"12","author":"Y Erdem","year":"1999","unstructured":"Erdem, Y., C. Usalan, I.C. Haznedaroglu, et al. 1999. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension. American Journal of Hypertension 12: 1071\u20131076.","journal-title":"American Journal of Hypertension"},{"key":"20_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","volume":"98","author":"CM Ferrario","year":"2006","unstructured":"Ferrario, C.M., and W.B. Strawn. 2006. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. The American Journal of Cardiology 98: 121\u2013128.","journal-title":"The American Journal of Cardiology"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00045391-200401000-00010","volume":"11","author":"CM Ferrario","year":"2004","unstructured":"Ferrario, C.M., R.S. Richmond, R. Smith, et al. 2004. Renin-angiotensin system as a therapeutic target in managing atherosclerosis. American Journal of Therapeutics 11: 44\u201353.","journal-title":"American Journal of Therapeutics"},{"key":"20_CR27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","volume":"90","author":"ZS Galis","year":"2002","unstructured":"Galis, Z.S., and J.J. Khatri. 2002. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circulation Research 90: 251\u2013262.","journal-title":"Circulation Research"},{"key":"20_CR28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11010-014-2221-1","volume":"398","author":"N Gao","year":"2015","unstructured":"Gao, N., H. Wang, X. Zhang, and Z. Yang. 2015. The inhibitory effect of angiotensin II on BKCa channels in podocytes via oxidative stress. Molecular and Cellular Biochemistry 398: 217\u2013222.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"20_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00277-004-0989-x","volume":"84","author":"H Goker","year":"2005","unstructured":"Goker, H., I.C. Haznedaroglu, Y. Beyazit, et al. 2005. Local umbilical cord blood renin-angiotensin system. Annals of Hematology 84: 277\u2013281.","journal-title":"Annals of Hematology"},{"key":"20_CR30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.fjc.0000137160.76616.cc","volume":"44","author":"M Graninger","year":"2004","unstructured":"Graninger, M., R. Reiter, C. Drucker, E. Minar, and B. Jilma. 2004. Angiotensin receptor blockade decreases markers of vascular inflammation. Journal of Cardiovascular Pharmacology 44: 335\u2013339.","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"3","key":"20_CR31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1076029606291403","volume":"12","author":"GS Guven","year":"2006","unstructured":"Guven, G.S., A. Kilicaslan, S.G. Oz, et al. 2006. Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity. Clinical and Applied Thrombosis\/Hemostasis 12(3): 364\u2013368.","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"20_CR32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.RES.84.6.695","volume":"84","author":"Y Han","year":"1999","unstructured":"Han, Y., M.S. Runge, and A.R. Brasier. 1999. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circulation Research 84: 695\u2013703.","journal-title":"Circulation Research"},{"key":"20_CR33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10557-004-6218-y","volume":"18","author":"M Hara","year":"2004","unstructured":"Hara, M., K. Ono, H. Wada, S. Sasayama, and A. Matsumori. 2004. Preformed angiotensin II is present in human mast cells. Cardiovascular Drugs and Therapy 18: 415\u2013420.","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"4","key":"20_CR34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1470320310379876","volume":"11","author":"IC Haznedaroglu","year":"2010","unstructured":"Haznedaroglu, I.C., and Y. Beyazit. 2010. Pathobiological aspects of the local bone marrow renin-angiotensin system: A review. Journal of the Renin-Angiotensin-Aldosterone System 11(4): 205\u2013213.","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"issue":"5","key":"20_CR35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/CS20120300","volume":"124","author":"IC Haznedaroglu","year":"2013","unstructured":"\u2014\u2014\u2014. 2013. Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis. Clinical Science (London, England) 124(5): 307\u2013323.","journal-title":"Clinical Science (London, England)"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1357-2725(02)00278-9","volume":"35","author":"IC Haznedaroglu","year":"2003","unstructured":"Haznedaroglu, I.C., and M.A. Ozturk. 2003. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. The International Journal of Biochemistry & Cell Biology 35: 867\u2013880.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"20_CR37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0306-9877(96)90122-X","volume":"46","author":"IC Haznedaroglu","year":"1996","unstructured":"Haznedaroglu, I.C., S. Tuncer, and M. Gursoy. 1996. A local renin-angiotensin system in the bone marrow. Medical Hypotheses 46: 507\u2013510.","journal-title":"Medical Hypotheses"},{"key":"20_CR38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1054\/mehy.1998.0830","volume":"54","author":"IC Haznedaroglu","year":"2000","unstructured":"Haznedaroglu, I.C., M. Arici, and Y. Buyukasik. 2000. A unifying hypothesis for the renin-angiotensin system and hematopoiesis: Sticking the pieces together with the JAK-STAT pathway. Medical Hypotheses 54: 80\u201383.","journal-title":"Medical Hypotheses"},{"key":"20_CR39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1681\/ASN.V1261211","volume":"12","author":"J Henegar","year":"2001","unstructured":"Henegar, J., S. Bigler, L. Henegar, S. Tyagi, and J. Hall. 2001. Functional and structural changes in the kidney in the early stages of obesity. Journal of the American Society of Nephrology 12: 1211\u20131217.","journal-title":"Journal of the American Society of Nephrology"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/01.CIR.95.6.1532","volume":"95","author":"M Hern\u00e1ndez-Presa","year":"1997","unstructured":"Hern\u00e1ndez-Presa, M., C. Bustos, M. Ortego, et al. 1997. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95: 1532\u20131541.","journal-title":"Circulation"},{"issue":"3","key":"20_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1590\/2359-3997000000134","volume":"60","author":"CL Herrera","year":"2016","unstructured":"Herrera, C.L., W. Castillo, P. Estrada, et al. 2016. Association of polymorphisms within the Renin-Angiotensin System with metabolic syndrome in a cohort of Chilean subjects. Archives of Endocrinology and Metabolism 60(3): 190\u2013198. doi: 10.1590\/2359-3997000000134 .","journal-title":"Archives of Endocrinology and Metabolism"},{"key":"20_CR42","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI116454","volume":"91","author":"H Itoh","year":"1993","unstructured":"Itoh, H., M. Mukoyama, R.E. Pratt, G.H. Gibbons, and V.J. Dzau. 1993. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. The Journal of Clinical Investigation 91: 2268\u20132274.","journal-title":"The Journal of Clinical Investigation"},{"key":"20_CR43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-5793(92)80071-N","volume":"298","author":"N Iwai","year":"1992","unstructured":"Iwai, N., and T. Inagami. 1992. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Letters 298: 257\u2013260.","journal-title":"FEBS Letters"},{"key":"20_CR44","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2006070707","volume":"18","author":"M Jurewicz","year":"2007","unstructured":"Jurewicz, M., et al. 2007. Human T and natural killer cells possess a functional renin-angiotensin system: Further mechanisms of angiotensin II-induced inflammation. Journal of the American Society of Nephrology 18: 1093\u20131102.","journal-title":"Journal of the American Society of Nephrology"},{"key":"20_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","volume":"13","author":"NS Kalupahana","year":"2012","unstructured":"Kalupahana, N.S., and N. Moustaid-Moussa. 2012a. The renin-angiotensin system: A link between obesity, inflammation and insulin resistance. Obesity Reviews 13: 136\u2013149.","journal-title":"Obesity Reviews"},{"key":"20_CR46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10409238.2012.694843","volume":"47","author":"NS Kalupahana","year":"2012","unstructured":"\u2014\u2014\u2014. 2012b. The adipose tissue renin-angiotensin system and metabolic disorders: A review of molecular mechanisms. Critical Reviews in Biochemistry and Molecular Biology 47: 379\u2013390.","journal-title":"Critical Reviews in Biochemistry and Molecular Biology"},{"key":"20_CR47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.blre.2014.09.010","volume":"29","author":"R Karmali","year":"2015","unstructured":"Karmali, R., A. Dalovisio, J.A. Borgia, et al. 2015. All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies. Blood Reviews 29: 71\u201380.","journal-title":"Blood Reviews"},{"key":"20_CR48","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1096\/fj.05-3820fje","volume":"19","author":"H Kato","year":"2005","unstructured":"Kato, H., J. Ishida, S. Imagawa, et al. 2005. Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. The FASEB Journal 19: 2023\u20132025.","journal-title":"The FASEB Journal"},{"key":"20_CR49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/labinvest.2008.42","volume":"88","author":"H Kato","year":"2008","unstructured":"Kato, H., J. Ishida, K. Nagano, et al. 2008. Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells. Laboratory Investigation 88: 731\u2013739.","journal-title":"Laboratory Investigation"},{"key":"20_CR50","first-page":"33","volume":"257","author":"ZS Katusic","year":"1989","unstructured":"Katusic, Z.S., and P.M. Vanhoutte. 1989. Superoxide anion is an endothelium-derived contracting factor. The American Journal of Physiology 257: 33\u201337.","journal-title":"The American Journal of Physiology"},{"key":"20_CR51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajh\/hpw003","volume":"29","author":"W Kawarazaki","year":"2016","unstructured":"Kawarazaki, W., and T. Fujita. 2016. The Role of aldosterone in obesity-related hypertension. American Journal of Hypertension 29: 415\u2013423.","journal-title":"American Journal of Hypertension"},{"issue":"4","key":"20_CR52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hfc.2012.06.012","volume":"8","author":"JA Kim","year":"2012","unstructured":"Kim, J.A., M. Montagnani, S. Chandrasekran, and M.J. Quon. 2012. Role of lipotoxicity in endothelial dysfunction. Heart Failure Clinics 8(4): 589\u2013607.","journal-title":"Heart Failure Clinics"},{"key":"20_CR53","first-page":"1243","volume":"99","author":"E Koca","year":"2007","unstructured":"Koca, E., I.C. Haznedaroglu, A. Uner, et al. 2007. Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin\u2019s disease. Journal of the National Medical Association 99: 1243\u20131247.","journal-title":"Journal of the National Medical Association"},{"key":"20_CR54","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","volume":"119","author":"H Kvakan","year":"2009","unstructured":"Kvakan, H., et al. 2009. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119: 2904\u2013U2983.","journal-title":"Circulation"},{"key":"20_CR55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/ajpregu.00758.2002","volume":"285","author":"B Lass\u00e8gue","year":"2003","unstructured":"Lass\u00e8gue, B., and R.E. Clempus. 2003. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 285: 277\u2013297.","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"20_CR56","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.95.3.588","volume":"95","author":"JB Laursen","year":"1997","unstructured":"Laursen, J.B., S. Rajagopalan, Z. Galis, M. Tarpey, B.A. Freeman, and D.G. Harrison. 1997. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588\u2013593.","journal-title":"Circulation"},{"key":"20_CR57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/oby.21352","volume":"24","author":"MJ LeMieux","year":"2016","unstructured":"LeMieux, M.J., L. Ramalingam, R.L. Mynatt, et al. 2016. Inactivation of adipose angiotensinogen reduces adipose tissue macrophages and increases metabolic activity. Obesity (Silver Spring) 24: 359\u2013367.","journal-title":"Obesity (Silver Spring)"},{"key":"20_CR58","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/eurheartj\/ehp078","volume":"30","author":"AM Leone","year":"2009","unstructured":"Leone, A.M., et al. 2009. From bone marrow to the arterial wall: The ongoing tale of endothelial progenitor cells. European Heart Journal 30: 890\u2013899.","journal-title":"European Heart Journal"},{"key":"20_CR59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1152\/ajprenal.00223.2015","volume":"310","author":"C Li","year":"2016","unstructured":"Li, C., Y. Lin, R. Luo, et al. 2016. Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney. American Journal of Physiology. Renal Physiology 310: 351\u2013363.","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"2","key":"20_CR60","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001559","volume":"4","author":"H Luo","year":"2015","unstructured":"Luo, H., X. Wang, C. Chen, et al. 2015. Oxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats. Journal of the American Heart Association 4(2): e001559. doi: 10.1161\/JAHA.114.001559 .","journal-title":"Journal of the American Heart Association"},{"key":"20_CR61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/351233a0","volume":"351","author":"TJ Murphy","year":"1991","unstructured":"Murphy, T.J., R.W. Alexander, K.K. Griendling, M.S. Runge, and K.E. Bernstein. 1991. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233\u2013236.","journal-title":"Nature"},{"key":"20_CR62","doi-asserted-by":"publisher","first-page":"10035","DOI":"10.1038\/srep10035","volume":"5","author":"A Nehme","year":"2015","unstructured":"Nehme, A., C. Cerutti, N. Dhaouadi, et al. 2015. Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis. Scientific Reports 5: 10035. doi: 10.1038\/srep10035 .","journal-title":"Scientific Reports"},{"key":"20_CR63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.jhh.1001714","volume":"18","author":"JM Neutel","year":"2004","unstructured":"Neutel, J.M. 2004. Effect of the renin\u2014angiotensin system on the vessel wall: Using ACE inhibition to improve endothelial function. Journal of Human Hypertension 18: 599\u2013606.","journal-title":"Journal of Human Hypertension"},{"key":"20_CR64","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.mehy.2004.04.011","volume":"63","author":"MA Ozturk","year":"2004","unstructured":"Ozturk, M.A., G.S. Guven, and I.C. Haznedaroglu. 2004. How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems. Medical Hypotheses 63: 866\u2013874.","journal-title":"Medical Hypotheses"},{"key":"20_CR65","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.CIR.100.15.1646","volume":"100","author":"L Pastore","year":"1999","unstructured":"Pastore, L., A. Tessitore, S. Martinotti, et al. 1999. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 100: 1646\u20131652.","journal-title":"Circulation"},{"key":"20_CR66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/db15-1690","volume":"65","author":"VB Patel","year":"2016","unstructured":"Patel, V.B., J. Mori, B.A. McLean, et al. 2016. ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity. Diabetes 65: 85\u201395.","journal-title":"Diabetes"},{"key":"20_CR67","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"M Paul","year":"2006","unstructured":"Paul, M., A. Poyan Mehr, and R. Kreutz. 2006. Physiology of local renin-angiotensin systems. Physiological Reviews 86: 747\u2013803.","journal-title":"Physiological Reviews"},{"key":"20_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-015-0509-4","volume":"76","author":"L Paulis","year":"2016","unstructured":"Paulis, L., S. Foulquier, P. Namsolleck, et al. 2016. Combined angiotensin receptor modulation in the management of cardio-metabolic disorders. Drugs 76: 1\u201312.","journal-title":"Drugs"},{"key":"20_CR69","first-page":"2124","volume":"102","author":"RP Pinto","year":"2004","unstructured":"Pinto, R.P., K.K. Wang, H. Khoury, A.D. Schimmer, and M.D. Minden. 2004. Aberrant expression of angiotensin in acute myeloid leukemia. Blood 102: 2124.","journal-title":"Blood"},{"key":"20_CR70","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/000331979504600203","volume":"46","author":"KA Robinson","year":"1995","unstructured":"Robinson, K.A., F.J. Candal, N.A. Scott, and E.W. Ades. 1995. Seeding of vascular grafts with an immortalized human dermal microvascular endothelial cell line. Angiology 46: 107\u2013113.","journal-title":"Angiology"},{"key":"20_CR71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.coph.2011.01.002","volume":"11","author":"AJM Roks","year":"2011","unstructured":"Roks, A.J.M., et al. 2011. Effects of the renin angiotensin system on vasculogenesis-related progenitor cells. Current Opinion in Pharmacology 11: 162\u2013174.","journal-title":"Current Opinion in Pharmacology"},{"key":"20_CR72","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/hy1201.100589","volume":"38","author":"M Ruiz-Ortega","year":"2001","unstructured":"Ruiz-Ortega, M., O. Lorenzo, M. Rup\u00e9rez, et al. 2001. Role of the renin-angiotensin system in vascular diseases: Expanding the field. Hypertension 38: 1382\u20131387.","journal-title":"Hypertension"},{"key":"20_CR73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2152\/jmi.57.12","volume":"57","author":"M Sata","year":"2010","unstructured":"Sata, M., and D. Fukuda. 2010. Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. The Journal of Medical Investigation 57: 12\u201325.","journal-title":"The Journal of Medical Investigation"},{"key":"20_CR74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3317\/jraas.2001.007","volume":"2","author":"PP Sayeski","year":"2001","unstructured":"Sayeski, P.P., and K.E. Bernstein. 2001. Signal transduction mechanisms of the angiotensin II type AT(1)-receptor: Looking beyond the heterotrimeric G protein paradigm. Journal of the Renin-Angiotensin-Aldosterone System 2: 4\u201310.","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"key":"20_CR75","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/147323000903700406","volume":"37","author":"M Sayitoglu","year":"2009","unstructured":"Sayitoglu, M., I.C. Haznedaroglu, O. Hatirnaz, et al. 2009. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia. The Journal of International Medical Research 37: 1018\u20131028.","journal-title":"The Journal of International Medical Research"},{"key":"20_CR76","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.RES.87.12.1195","volume":"87","author":"B Schieffer","year":"2000","unstructured":"Schieffer, B., M. Luchtefeld, S. Braun, A. Hilfiker, D. Hilfiker-Kleiner, and H. Drexler. 2000. Role of NAD(P)H oxidase in angiotensin II-induced JAK\/STAT signaling and cytokine induction. Circulation Research 87: 1195\u20131201.","journal-title":"Circulation Research"},{"key":"20_CR77","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00005344-199016004-00009","volume":"16","author":"T Scott-Burden","year":"1990","unstructured":"Scott-Burden, T., A.W. Hahn, T.J. Resink, and F.R. B\u00fchler. 1990. Modulation of extracellular matrix by angiotensin II: Stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. Journal of Cardiovascular Pharmacology 16: 36\u201341.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"20_CR78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/ehm.09.4","volume":"2","author":"II Slukvin","year":"2009","unstructured":"Slukvin, I.I. 2009. Renin angiotensin system and hemangioblast development from human embryonic stem cells. Expert Review of Hematology 2: 137\u2013143.","journal-title":"Expert Review of Hematology"},{"key":"20_CR79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00281-009-0141-z","volume":"31","author":"O Soehnlein","year":"2009","unstructured":"Soehnlein, O., and C. Weber. 2009. Myeloid cells in atherosclerosis: Initiators and decision shapers. Seminars in Immunopathology 31: 35\u201347.","journal-title":"Seminars in Immunopathology"},{"key":"20_CR80","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/labinvest.2010.190","volume":"91","author":"MJ Sopel","year":"2011","unstructured":"Sopel, M.J., et al. 2011. Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells. Laboratory Investigation 91: 565\u2013578.","journal-title":"Laboratory Investigation"},{"key":"20_CR81","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/HYPERTENSIONAHA.109.134213","volume":"55","author":"M Steinmetz","year":"2010","unstructured":"Steinmetz, M., et al. 2010. Endothelial-regenerating cells an expanding universe. Hypertension 55: 593\u2013599.","journal-title":"Hypertension"},{"key":"20_CR82","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.atherosclerosis.2007.06.024","volume":"196","author":"WB Strawn","year":"2008","unstructured":"Strawn, W.B., and C.M. Ferrario. 2008. Angiotensin II AT(1) receptor blockade normalizes CD11b(+) monocyte production in bone marrow of hypercholesterolemic monkeys. Atherosclerosis 196: 624\u2013632.","journal-title":"Atherosclerosis"},{"key":"20_CR83","unstructured":"Strawn, W., R. Richmond, and C. Ferrario. 2003. A new understanding of atherosclerosis: The bone marrow response-to-lipid hypothesis. In Heart Disease: Pathogenesis, Diagnosis and Treatment (3rd World Congress on Heart Disease), 183\u2013188. Washington, DC."},{"key":"20_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1587594","volume":"2016","author":"J Sun","year":"2016","unstructured":"Sun, J., J. Luo, Y. Ruan, et al. 2016. Free fatty acids activate renin-angiotensin system in 3T3-L1 adipocytes through nuclear factor-kappa B pathway. Journal of Diabetes Research 2016: 1587594. doi: 10.1155\/2016\/1587594 .","journal-title":"Journal of Diabetes Research"},{"key":"20_CR85","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1073\/pnas.95.7.4061","volume":"95","author":"RS Surwit","year":"1998","unstructured":"Surwit, R.S., S. Wang, A.E. Petro, S. Raimbault, D. Ricquier, and S. Collins. 1998. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proceedings of the National Academy of Sciences of the United States of America 95: 4061\u20134065.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"20_CR86","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1158\/0008-5472.CAN-06-0458","volume":"66","author":"A Takeda","year":"2006","unstructured":"Takeda, A., C. Goolsby, and N.R. Yaseen. 2006. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. Cancer Research 66: 6628\u20136637.","journal-title":"Cancer Research"},{"key":"20_CR87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cardiores.2006.01.002","volume":"70","author":"T Thum","year":"2006","unstructured":"Thum, T., et al. 2006. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovascular Research 70: 50\u201360.","journal-title":"Cardiovascular Research"},{"key":"20_CR88","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.HYP.33.5.1169","volume":"33","author":"L Tiret","year":"1999","unstructured":"Tiret, L., O. Poirier, V. Hallet, T. McDonagh, C. Morrison, J. McMurray, H. Dargie, D. Arveiler, J. Ruidavets, G. Luc, A. Evans, and F. Cambien. 1999. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33: 1169\u20131174.","journal-title":"Hypertension"},{"key":"20_CR89","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1113\/expphysiol.2005.030080","volume":"90","author":"RM Touyz","year":"2005","unstructured":"Touyz, R.M. 2005. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II. Experimental Physiology 90: 449\u2013455.","journal-title":"Experimental Physiology"},{"key":"20_CR90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0895-7061(95)00349-5","volume":"9","author":"H Urata","year":"1996","unstructured":"Urata, H., H. Nishimura, and D. Ganten. 1996. Chymase-dependent angiotensin II forming systems in humans. American Journal of Hypertension 9: 277\u2013284.","journal-title":"American Journal of Hypertension"},{"key":"20_CR91","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.HYP.25.5.913","volume":"25","author":"B Williams","year":"1995","unstructured":"Williams, B., A.Q. Baker, B. Gallacher, and D. Lodwick. 1995. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25: 913\u2013917.","journal-title":"Hypertension"},{"key":"20_CR92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002770050215","volume":"73","author":"GG Wulf","year":"1996","unstructured":"Wulf, G.G., G. Jahns-Streubel, F. Strutz, et al. 1996. Paraneoplastic hypokalemia in acute myeloid leukemia: A case of renin activity in AML blast cells. Annals of Hematology 73: 139\u2013141.","journal-title":"Annals of Hematology"},{"key":"20_CR93","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.107.147124","volume":"27","author":"T Yamada","year":"2007","unstructured":"Yamada, T., T. Kondo, Y. Numaguchi, et al. 2007. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 2363\u20132369.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"20_CR94","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/01.ATV.18.9.1433","volume":"18","author":"BC Yang","year":"1998","unstructured":"Yang, B.C., M.I. Phillips, D. Mohuczy, H. Meng, L. Shen, P. Mehta, and J.L. Mehta. 1998. Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arteriosclerosis, Thrombosis, and Vascular Biology 18: 1433\u20131439.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"20_CR95","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biocel.2005.09.013","volume":"38","author":"BO Yildiz","year":"2006","unstructured":"Yildiz, B.O., and I.C. Haznedaroglu. 2006. Rethinking leptin and insulin action: Therapeutic opportunities for diabetes. The International Journal of Biochemistry & Cell Biology 38: 820\u2013830.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"20_CR96","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood-2008-03-144766","volume":"112","author":"ET Zambidis","year":"2008","unstructured":"Zambidis, E.T., T. Soon Park, W. Yu, et al. 2008. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112: 3601\u20133614.","journal-title":"Blood"},{"key":"20_CR97","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coph.2011.02.006","volume":"11","author":"IH Zucker","year":"2011","unstructured":"Zucker, I.H., and M.C. Zimmerman. 2011. The renin-angiotensin system in 2011: New avenues for translational research. Current Opinion in Pharmacology 11: 101\u2013104.","journal-title":"Current Opinion in Pharmacology"}],"container-title":["Advances in Experimental Medicine and Biology","Obesity and Lipotoxicity"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-48382-5_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:56:00Z","timestamp":1750290960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-48382-5_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319483801","9783319483825"],"references-count":97,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-48382-5_20","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2017]]}}}